Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
International Flavors & Fragrances
IFF
|
$159M |
| 2 |
Broadcom
AVGO
|
$140M |
| 3 |
Builders FirstSource
BLDR
|
$128M |
| 4 |
Equinix
EQIX
|
$98.7M |
| 5 |
ConocoPhillips
COP
|
$89.1M |
Top Sells
| 1 |
GameStop
GME
|
$746M |
| 2 |
Chevron
CVX
|
$276M |
| 3 |
Apple
AAPL
|
$238M |
| 4 |
BMCH
BMC Stock Holdings, Inc
BMCH
|
$197M |
| 5 |
CHL
China Mobile Limited
CHL
|
$178M |
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.68% |
| 3 | Industrials | 13.59% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Healthcare | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NKLA
3151
DELISTED
Nikola Corporation Common Stock
NKLA
| $472K | ﹤0.01% |
+33,995
| New | +$472K |
|
3152
Old Point Financial
OPOF
$215M
| $471K | ﹤0.01% |
20,012
| – | – |
|
3153
XBiotech
XBIT
$92.1M
| $471K | ﹤0.01% |
27,416
| – | – |
|
|
RUBY
3154
DELISTED
Rubius Therapeutics, Inc
RUBY
| $471K | ﹤0.01% |
17,757
+5,196
| +41% | +$138K |
|
3155
Aclaris Therapeutics
ACRS
$216M
| $470K | ﹤0.01% |
18,640
| – | – |
|
3156
Avalon Holdings
AWX
$9.75M
| $470K | ﹤0.01% |
128,178
+2,878
| +2% | +$10.6K |
|
3157
Amicus Therapeutics
FOLD
$2.43B
| $467K | ﹤0.01% |
47,228
-63,994
| -58% | -$633K |
|
3158
Copel
ELP
$6.59B
| $465K | ﹤0.01% |
371,890
+331,201
| +814% | +$414K |
|
3159
Reynolds Consumer Products
REYN
$4.89B
| $463K | ﹤0.01% |
15,535
-2,085
| -12% | -$62.1K |
|
3160
Comstock
LODE
$118M
| $461K | ﹤0.01% |
+100,642
| New | +$461K |
|
3161
Marchex
MCHX
$87M
| $459K | ﹤0.01% |
163,493
+24,339
| +17% | +$68.3K |
|
3162
WidePoint Corp
WYY
$48.2M
| $455K | ﹤0.01% |
49,486
+33,561
| +211% | +$309K |
|
|
MTL
3163
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $451K | ﹤0.01% |
261,171
-14,684
| -5% | -$25.4K |
|
3164
Caledonia Mining Corp
CMCL
$509M
| $450K | ﹤0.01% |
31,478
+2,812
| +10% | +$40.2K |
|
3165
Wipro
WIT
$28.9B
| $450K | ﹤0.01% |
+70,972
| New | +$450K |
|
3166
Hovnanian Enterprises
HOV
$803M
| $446K | ﹤0.01% |
+4,222
| New | +$446K |
|
3167
Beam Therapeutics
BEAM
$1.65B
| $440K | ﹤0.01% |
+5,499
| New | +$440K |
|
3168
Air T
AIRT
$59.1M
| $438K | ﹤0.01% |
18,425
+4,441
| +32% | +$106K |
|
|
PCOM
3169
DELISTED
Points.com Inc. Common Shares
PCOM
| $436K | ﹤0.01% |
29,034
-1,144
| -4% | -$17.2K |
|
3170
Telus
TU
$24.9B
| $428K | ﹤0.01% |
21,480
| – | – |
|
3171
Trio-Tech International
TRT
$22.9M
| $427K | ﹤0.01% |
95,008
+7,220
| +8% | +$32.4K |
|
|
XXII
3172
22nd Century Group
XXII
$6.29M
| $427K | ﹤0.01% |
129,649
+112,635
| +662% | +$371K |
|
3173
Exicure
XCUR
$34.6M
| $420K | ﹤0.01% |
+192,678
| New | +$420K |
|
3174
Solid Biosciences
SLDB
$423M
| $416K | ﹤0.01% |
74,931
| – | – |
|
3175
Global Water Resources
GWRS
$257M
| $415K | ﹤0.01% |
25,430
+9,372
| +58% | +$153K |
|